from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3581c/ispF

LFCtreatmentdescriptionclass of inhibitor

0.237

Amikacinug/mL Amikacintranslation

-0.851

Cap5-10ug/mL Capreomycintranslation

0.057

Rox10-50 ug/mL Roxithromycintranslation

0.027

SM2-5 ug/mL Streptomycintranslation

1.023

Tet5-10 ug/mL Tetracyclinetranslation

0.704

Rif0.2-5ug/mL Rifampicintranscription

0.749

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.760

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.091

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.121

CPZ10-50 ug/mL Chlorpromazinerespiration

0.571

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.286

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.860

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.553

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.716

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.821

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.087

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.291

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.359

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.489

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.326

KCN5-20 ug/mL Potassium cyaniderespiration

-0.123

NaN30.2-2 mM Sodium aziderespiration

-0.988

Nigericin50 uM Nigericinrespiration

0.347

TRC10-150 ug/mL Triclosanrespiration

0.616

TRZ10-25 ug/mL Thioridazinerespiration

1.952

Valinomycin0.5-10 uM Valinomycinrespiration

-1.986

ZnSO42 mM ZnSO4respiration

-0.340

menadione6-10 ug/mL Menadionerespiration

-0.381

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.849

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.491

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.100

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.932

NRP_1Non-replicating persistence stage 1dosRassociated

0.481

Amp0.2mg/mL AmpicillincellWall

-0.596

Cephalexin20-100 ug/mL CephalexincellWall

-1.095

Cerulenin0.32-5 ug/mL CerulenincellWall

0.384

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.043

EMB10-20 ug/mL EthambutolcellWall

-0.484

Eta12-40 ug/mL EthionamidecellWall

-0.300

INH0.2-0.4 ug/mL IsoniazidcellWall

0.074

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.354

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.583

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.065

BZA0.12 mg/mL BenzamidearomaticAmides

0.101

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.111

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.075

H2O24 mM hydrogen peroxideDNAdamaging

-0.691

Levo10 ug/mL LevofloxacinDNAdamaging

0.211

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.168

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.497

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.180

UVUV-irradiationDNAdamaging

1.360

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.580

Antimycin12.5-50 ug/mL Antimycin A?

-0.893

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.664

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.151

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.096

PA8240.2-2 ug/mL PA-824?

0.602

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.222

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.392

Verapamil50 uM Verapamil?

-0.133

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.233

methoxatin10-20 ug/mL Methoxatin?